Eculizumab followed by allogeneic hematopoietic stem cell transplantation (HSCT) for hemolytic paroxysmal nocturnal hemoglobinurea/severe aplastic anemia (hPNH/SAA)

被引:0
|
作者
Kulagin, A. [1 ]
Klimova, O. [1 ]
Rudakova, T. [1 ]
Golubovskaya, I. [1 ]
Smirnova, A. [1 ]
Ovetchkina, V. [1 ]
Gudozhnikova, Y. [1 ]
Zalyalov, Y. [1 ]
Slesarchuk, O. [1 ]
Babenko, E. [1 ]
Estrina, M. [1 ]
Alyanskiy, A. [1 ]
Bondarenko, S. [1 ]
Afanasyev, B. [1 ]
机构
[1] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O153
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 50 条
  • [1] FEASIBILITY AND OPTIMAL SCHEDULE OF USING ECULIZUMAB IN PATIENTS WITH HEMOLYTIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (HPNH) WITH SEVERE APLASTIC ANEMIA (SAA) PRIOR TO HAEMOPOIETIC STEM CELL TRANSPLANT (HSCT)
    Kulasekararaj, A.
    Potter, V.
    Gandhi, S.
    Mclornan, D.
    Delavallade, H.
    Kavita, R.
    Benson-Quarm, N.
    Large, J.
    Kenyon, M.
    Pagliuca, A.
    Mufti, G.
    Marsh, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S123 - S123
  • [2] Feasibility and Optimal Schedule Of Using Eculizumab In Patients With Hemolytic Paroxysmal Nocturnal Hemoglobinuria (hPNH) With Severe Aplastic Anemia (SAA) Prior To Haemopietic Stem Cell Transplant (HSCT)
    Kulasekararaj, Austin G.
    Potter, Victoria T.
    Gandhi, Shreyans A.
    Benson-Quarm, Nana
    Large, Joanna
    Pagliuca, Antonio
    Mufti, Ghulam J.
    Marsh, Judith
    BLOOD, 2013, 122 (21)
  • [3] Feasibility and optimal schedule of eculizumab in patients with haemolytic paroxysmal nocturnal hemoglobinuria (hPNH) with severe aplastic anaemia (SAA) prior to haemopoietic stem cell transplant (HSCT)
    Kulasekararaj, A. G.
    Hill, A.
    Farmer, I.
    Riley, K.
    Arnold, L.
    Allam, R.
    Gandhi, S.
    Griffin, M.
    Munir, T.
    Large, J.
    Potter, V.
    Mufti, G. J.
    Pagliuca, A.
    Hillmen, P.
    Marsh, J. C. W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 16 - 16
  • [4] Allogeneic hematopoietic stem cell transplantation (HSCT) with an unrelated donor as first-line therapy in patients with severe aplastic anemia (SAA)
    Tichelli, A.
    Passweg, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 28 - 28
  • [5] Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome
    Liu, Limin
    Zhou, Huifen
    Wang, Qingyuan
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Fu, Chengcheng
    Jin, Zhengming
    Chen, Suning
    Sun, Aining
    Miao, Miao
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2019, 54 : 346 - 347
  • [7] State of the Art Aplastic anemia: The importance of allogeneic hematopoietic stem cell transplantation (HSCT)
    Tichelli, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 115 - 115
  • [8] Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
    Goker, Hakan
    Uz, Burak
    Buyukasik, Yahya
    Aksu, Salih
    Haznedaroglu, Ibrahim
    Sayinalp, Nilgun
    Karacan, Yasemin
    Tekin, Fatma
    Ozcebe, Osman Ilhami
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (03) : 223 - 227
  • [9] INCIDENCE AND RISK FACTORS FOR HEMOLYTIC PAROXYSMAL NOCTURNAL HEMOGLOBINUREA (PNH) IN APLASTIC ANEMIA (AA) PATIENTS
    Kulagin, A.
    Golubovskaya, I.
    Ivanova, M.
    Babenko, E.
    Pronkina, N.
    Kruchkova, I.
    Lisukov, I.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S42 - S43
  • [10] Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia
    K Kudo
    H Muramatsu
    N Yoshida
    R Kobayashi
    H Yabe
    K Tabuchi
    K Kato
    K Koh
    Y Takahashi
    Y Hashii
    Y Kawano
    M Inoue
    Y Cho
    H Sakamaki
    K Kawa
    K Kato
    R Suzuki
    S Kojima
    Bone Marrow Transplantation, 2015, 50 : 1312 - 1315